Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen

Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen

US Patent 8501693 · Granted Aug 6, 2013

Estimated economic value: $10,790,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fastening device for a window lifter, and window lifter2025
Driver element for a motor vehicle window lifter2024
Window lift system and motor vehicle door2024
Motor vehicle door2023
Fastening device for a window lifter, and window lifter2023
Method for assessing auditory attention and vigilance2013
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver dis2013
Chronic treatment regimen using glucagon-like insulinotropic peptides2011
Chronic treatment regimen using glucagon-like insulinotropic peptides2007
Biphasic mixtures of GLP-1 and insulin2007
Methods for screening and identifying host pathogen defense genes2006